ES2582802T3 - Uso de lisozima como marcador - Google Patents

Uso de lisozima como marcador Download PDF

Info

Publication number
ES2582802T3
ES2582802T3 ES13700913.0T ES13700913T ES2582802T3 ES 2582802 T3 ES2582802 T3 ES 2582802T3 ES 13700913 T ES13700913 T ES 13700913T ES 2582802 T3 ES2582802 T3 ES 2582802T3
Authority
ES
Spain
Prior art keywords
protein
marker
lysozyme
polypeptide
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13700913.0T
Other languages
English (en)
Spanish (es)
Inventor
Stefan HAERTLE
Sebastian Jaeger
Daniela Daubert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morphosys GmbH
Original Assignee
Morphosys GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphosys GmbH filed Critical Morphosys GmbH
Application granted granted Critical
Publication of ES2582802T3 publication Critical patent/ES2582802T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES13700913.0T 2012-01-23 2013-01-23 Uso de lisozima como marcador Active ES2582802T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261589408P 2012-01-23 2012-01-23
EP12152095 2012-01-23
US201261589408P 2012-01-23
EP12152095 2012-01-23
PCT/EP2013/051181 WO2013110627A1 (en) 2012-01-23 2013-01-23 Use of lysozyme as a tag

Publications (1)

Publication Number Publication Date
ES2582802T3 true ES2582802T3 (es) 2016-09-15

Family

ID=48872896

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13700913.0T Active ES2582802T3 (es) 2012-01-23 2013-01-23 Uso de lisozima como marcador

Country Status (10)

Country Link
US (1) US9689014B2 (enExample)
EP (1) EP2807179B1 (enExample)
JP (1) JP6215231B2 (enExample)
KR (1) KR20140122729A (enExample)
CN (1) CN104066745B (enExample)
AU (1) AU2013211651C1 (enExample)
CA (1) CA2860916A1 (enExample)
ES (1) ES2582802T3 (enExample)
IN (1) IN2014DN06660A (enExample)
WO (1) WO2013110627A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105524942A (zh) * 2016-02-05 2016-04-27 广州赛莱拉干细胞科技股份有限公司 一种表达载体及胰岛素样生长因子结合蛋白3的表达方法
US10986850B2 (en) 2016-12-21 2021-04-27 Novozymes A/S Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
EP3612212A4 (en) 2016-12-21 2020-10-21 Novozymes A/S POLYPEPTIDES HAVING LYSOZYME ACTIVITY, POLYNUCLEOTIDES CODING THEREOF AND USES AND COMPOSITIONS OF THEM
CN107794254A (zh) * 2017-09-30 2018-03-13 昆明理工大学 重组高温裂解酶的快速纯化方法
CN116568792A (zh) * 2020-12-16 2023-08-08 丹尼斯科美国公司 用于清洁的酶和酶组合物
WO2023168234A1 (en) * 2022-03-01 2023-09-07 Danisco Us Inc. Enzymes and enzyme compositions for cleaning
WO2025179145A1 (en) * 2024-02-23 2025-08-28 Dualitas Therapeutics, Inc. Bispecific screening compositions and methods

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2459701A (en) 1945-07-16 1949-01-18 Harper Esther Pardee Mechanical instrument holder
US4355022A (en) 1981-07-01 1982-10-19 Interon, Inc. Method of dental treatment
JP2761881B2 (ja) * 1988-03-10 1998-06-04 チッソ株式会社 抗体を固定化したアフイニテイクロマトグラフイ用担体
EP0425016B1 (en) 1989-10-27 1995-12-20 The Procter & Gamble Company Antimicrobial method and formulation employing type II endoglycosidase and antimicrobial agent
DE59812393D1 (de) 1997-08-22 2005-01-20 Siemens Ag Verfahren zur klopfregelung einer brennkraftmaschine
JP2002527046A (ja) 1998-10-15 2002-08-27 デーエスエム・ナムローゼ・フェンノートシャップ 動物飼料中における抗微生物酵素
WO2001000855A1 (en) * 1999-06-23 2001-01-04 Ppl Therapeutics (Scotland) Ltd. Fusion proteins incorporating lysozyme
CA2472477C (en) 2002-01-07 2012-03-20 Lifesensors, Inc. Methods and compositions for protein expression and purification
DE10237317B4 (de) 2002-08-15 2010-04-08 3M Espe Ag Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
CA2404356A1 (en) 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
US7428273B2 (en) 2003-09-18 2008-09-23 Promptu Systems Corporation Method and apparatus for efficient preamble detection in digital data receivers
JP4891220B2 (ja) 2004-02-25 2012-03-07 ノボザイムス アクティーゼルスカブ 菌類細胞壁分解酵素
US8119600B2 (en) 2007-04-10 2012-02-21 Stefano Ferrari Compositions containing lysozyme and C-1/C-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology
WO2009051769A1 (en) * 2007-10-17 2009-04-23 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for crystallizing g protein-coupled receptors
CN101817883B (zh) * 2010-03-12 2012-06-13 广东药学院 一种家蝇天蚕素-人溶菌酶融合蛋白及其制备方法和应用

Also Published As

Publication number Publication date
IN2014DN06660A (enExample) 2015-05-22
JP6215231B2 (ja) 2017-10-18
CN104066745B (zh) 2017-04-12
AU2013211651B2 (en) 2017-03-02
KR20140122729A (ko) 2014-10-20
AU2013211651C1 (en) 2017-10-12
CA2860916A1 (en) 2013-08-01
EP2807179A1 (en) 2014-12-03
AU2013211651A1 (en) 2014-07-24
WO2013110627A1 (en) 2013-08-01
US20140349343A1 (en) 2014-11-27
US9689014B2 (en) 2017-06-27
EP2807179B1 (en) 2016-04-20
CN104066745A (zh) 2014-09-24
HK1202298A1 (en) 2015-09-25
JP2015504683A (ja) 2015-02-16

Similar Documents

Publication Publication Date Title
AU2014259474B2 (en) Stabilized soluble prefusion RSV F polypeptides
ES2675784T3 (es) Polipéptidos de fusión que comprenden ligador de polipéptidos de dominio de mucina
AR080942A1 (es) Produccion de proteinas heteromultimericas
KR101915740B1 (ko) 목적 단백질의 발현 효율을 증진시키기 위한 신규한 펩타이드 및 이를 포함하는 융합 단백질
JP2012531208A5 (enExample)
CN109627294B (zh) 一种正确折叠的重组狂犬病毒g蛋白胞外段及其潜在应用
KR101219628B1 (ko) 인터날린 단백질의 ｎ-말단 및 ｌｒｒ 패밀리 단백질이 융합된 수용성 융합 폴리펩타이드 및 이의 제조 방법
EP2807179B1 (en) Use of lysozyme as a tag
IL309260B1 (en) Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin fc compositions with enhanced complement binding
RU2015105330A (ru) Укороченные варианты cd95-f-c
EP2881403A1 (en) Scavenger containing protein formed from tandem-type multimer of mutant extracellular domain of protein g
WO2022032660A1 (zh) 新型冠状病毒rbd融合蛋白
US20140221613A1 (en) Novel modified protein comprising tandem-type multimer of mutant extracellular domain of protein g
CN116655750A (zh) 一种prrsv m蛋白sla-1*04:01:01限制性t细胞表位多肽及其应用
KR102060881B1 (ko) 재조합 인간 혈청 알부민의 수용성 과발현 및 정제 방법
KR101342974B1 (ko) 신규 펩티드 태그 및 이의 용도
RU2018141714A (ru) Слитый белок, содержащий вариант CCL3, и его применение
US9163069B2 (en) Fusion proteins representing different allergens and a vaccine against allergy to mites
Pyo et al. A large-scale purification of recombinant histone H1. 5 from Escherichia coli
WO2018122777A1 (es) Una secuencia peptídica de una proteína guía para la producción de un péptido de interés; un vector de expresión; una célula huésped; un proceso para para la producción de un péptido de interés
CN105198999A (zh) 一种融合蛋白、其制备方法及其应用
Ng et al. Purification, crystallization and preliminary X-ray diffraction analysis of the HMG domain of Sox17 in complex with DNA
Prabhala Advances in affinity-based methods for downstream process development of monoclonal antibody and recombinant protein therapeutics
Cheng et al. Expression, Purification, and Crystallization of the Vγ9Vδ2 T-cell Receptor Recognizing Protein/Peptide Antigens
Qian Mouse Trp4 and its associated proteins.